Last reviewed · How we verify
NCT07205068
Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure
NA trial testing Shockwave M5 IVL Catheter in Aortic Stenosis in 100 participants. Currently enrolling.
4 November 2026
Quick facts
| Lead sponsor | University of Tennessee Graduate School of Medicine |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 4 October 2025 |
| Primary completion | 4 November 2026 |
| Estimated completion | 4 November 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Shockwave M5 IVL Catheter
- Modified Seldinger Technique
- Modified Seldinger Technique
Conditions studied
- Aortic Stenosis — all drugs for Aortic Stenosis →
Sponsor
University of Tennessee Graduate School of Medicine
Who can join
18 and older, any sex, with Aortic Stenosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary purpose of this study is to observe reduced access site complications in patients with heavily calcified common femoral arteries requiring Transcatheter Aortic Valve Replacement (TAVR)
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07205068
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aortic Stenosis
Currently open trials in the same condition.
- NCT07197736 — DELINEATE-Prospective · recruiting
- NCT07230964 — Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacemen · NA · recruiting
- NCT07052071 — Impact of Transcatheter Aortic Valve Implantation (TAVI) on the Gut Microbiota in Patients With Aortic Valve Stenosis · recruiting
- NCT07144189 — AI Assessment of Low-Gradient Aortic Stenosis Severity Based on Echocardiography · recruiting
- NCT06924151 — Isolated Surgical Aortic Valve Replacement in Low Risk AS Patients · NA · recruiting
Other University of Tennessee Graduate School of Medicine trials
Trials by the same sponsor.
- NCT07223437 — REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennesse · NA · not yet recruiting
- NCT07214012 — Planning Together: A Couple-based, Multi-level Prenatal Contraceptive Education Program for Economically Marginalized Fa · NA · not yet recruiting
- NCT06953635 — Quadratus Lumborum Versus Placebo in Open Ventral Hernia Repair · NA · not yet recruiting
- NCT07153614 — Efficacy of Perioperative Opioid Sparing Techniques on Time to Initiation of Chemotherapy · NA · recruiting
- NCT06802861 — Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclam · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07205068 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Tennessee Graduate School of Medicine
- Last refreshed: 3 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07205068.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing